Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell-type-specific CAG repeat expansions and toxicity of mutant Huntingtin in human striatum and cerebellum. | Nat Genet | 2024 | 38291334 | PubTator, text mining | PubMed |
| Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes. | Hum Genomics | 2024 | 38287404 | PubTator, text mining | PubMed |
| Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma. | BMC Med | 2024 | 38281914 | PubTator, text mining | PubMed |
| High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer. | Neoplasia | 2024 | 38281411 | PubTator, text mining | PubMed |
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population. | J Transl Med | 2024 | 38280995 | PubTator, text mining | PubMed |
| Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells. | Cell Mol Biol Lett | 2024 | 38267862 | PubTator, text mining | PubMed |
| Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 mice. | Sci Rep | 2024 | 38267530 | PubTator, text mining | PubMed |
| D-type cyclins regulate DNA mismatch repair in the G1 and S phases of the cell cycle, maintaining genome stability. | bioRxiv | 2024 | 38260436 | PubTator, text mining | PubMed |
| Role of Epigenetics for the Efficacy of Cisplatin. | Int J Mol Sci | 2024 | 38256203 | PubTator, text mining | PubMed |
| Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications. | Int J Mol Sci | 2024 | 38256131 | PubTator, text mining | PubMed |
| Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis. | Acta Neuropathol Commun | 2024 | 38254245 | PubTator, text mining | PubMed |
| Compound heterozygous MSH3 germline variants and associated tumor somatic DNA mismatch repair dysfunction. | NPJ Precis Oncol | 2024 | 38243056 | PubTator, text mining | PubMed |
| Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients. | BMC Cancer | 2024 | 38238650 | PubTator, text mining | PubMed |
| DNA mismatch repair system regulates the expression of PD-L1 through DNMTs in cervical cancer. | Cancer Cell Int | 2024 | 38200495 | PubTator, text mining | PubMed |
| A pilot study to evaluate the expression of microRNA‑let‑7a in patients with intestinal‑type sinonasal adenocarcinoma. | Oncol Lett | 2024 | 38192674 | PubTator, text mining | PubMed |
| SVvalidation: A long-read-based validation method for genomic structural variation. | PLoS One | 2024 | 38181020 | PubTator, text mining | PubMed |
| A unifying model that explains the origins of human inverted copy number variants. | PLoS Genet | 2024 | 38175827 | PubTator, text mining | PubMed |
| Template switching between the leading and lagging strands at replication forks generates inverted copy number variants through hairpin-capped extrachromosomal DNA. | PLoS Genet | 2024 | 38175823 | PubTator, text mining | PubMed |
| Dynamic regulation of EXO1 promotes the progression from liver fibrosis to HCC through TGF-β1/Smad signaling feedback loop. | Hepatol Commun | 2024 | 38126949 | PubTator, text mining | PubMed |
| Complex rearrangement in TBC1D4 in an individual with diabetes due to severe insulin resistance syndrome. | Eur J Hum Genet | 2024 | 38086948 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=7